aluates Reports

$ 0.0

Automative

Global Antiviral Medications for Seasonal Influenza Market Research Report 2025

Published Date: 2025-02-07

Report Code: QYRE-Auto-23Z18537

BUY CHAPTERS

Global Antiviral Medications for Seasonal Influenza Market Research Report 2025

Code: QYRE-Auto-23Z18537

Report

2025-02-07

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Antiviral Medications for Seasonal Influenza Market Size

The global market for Antiviral Medications for Seasonal Influenza was valued at US$ 921 million in the year 2024 and is projected to reach a revised size of US$ 1510 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Antiviral Medications for Seasonal Influenza Market

Seasonal influenza antiviral drugs are a class of drugs specifically used to prevent and treat seasonal influenza caused by influenza viruses. These drugs work by directly acting on the virus or inhibiting its replication process, thereby alleviating symptoms, shortening the course of the disease, and reducing the risk of complications. Common antiviral drugs include neuraminidase inhibitors and M2 ion channel inhibitors.

North American market for Antiviral Medications for Seasonal Influenza is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antiviral Medications for Seasonal Influenza is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antiviral Medications for Seasonal Influenza include Roche, HEC Pharma, Qilu Pharmaceutical, CSPC, Kelun, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiviral Medications for Seasonal Influenza, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Medications for Seasonal Influenza.

The Antiviral Medications for Seasonal Influenza market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiviral Medications for Seasonal Influenza market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiviral Medications for Seasonal Influenza manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antiviral Medications for Seasonal Influenza Market Report

Report Metric	Details
Report Name	Antiviral Medications for Seasonal Influenza Market
Accounted market size in year	US$ 921 million
Forecasted market size in 2031	US$ 1510 million
CAGR	7.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Baloxavir marboxil Oseltamivir Zanamivir Peramivir
Segment by Application	Influenza A Influenza B
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, HEC Pharma, Qilu Pharmaceutical, CSPC, Kelun
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiviral Medications for Seasonal Influenza manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiviral Medications for Seasonal Influenza in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antiviral Medications for Seasonal Influenza Market growing?

Ans: The Antiviral Medications for Seasonal Influenza Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Antiviral Medications for Seasonal Influenza Market size in 2031?

Ans: The Antiviral Medications for Seasonal Influenza Market size in 2031 will be US$ 1510 million.

Who are the main players in the Antiviral Medications for Seasonal Influenza Market report?

Ans: The main players in the Antiviral Medications for Seasonal Influenza Market are Roche, HEC Pharma, Qilu Pharmaceutical, CSPC, Kelun

What are the Application segmentation covered in the Antiviral Medications for Seasonal Influenza Market report?

Ans: The Applications covered in the Antiviral Medications for Seasonal Influenza Market report are Influenza A, Influenza B

What are the Type segmentation covered in the Antiviral Medications for Seasonal Influenza Market report?

Ans: The Types covered in the Antiviral Medications for Seasonal Influenza Market report are Baloxavir marboxil, Oseltamivir, Zanamivir, Peramivir

1 Antiviral Medications for Seasonal Influenza Market Overview

1.1 Product Definition

1.2 Antiviral Medications for Seasonal Influenza by Type

1.2.1 Global Antiviral Medications for Seasonal Influenza Market Value Comparison by Type (2024 VS 2031)

1.2.2 Baloxavir marboxil

1.2.3 Oseltamivir

1.2.4 Zanamivir

1.2.5 Peramivir

1.3 Antiviral Medications for Seasonal Influenza by Application

1.3.1 Global Antiviral Medications for Seasonal Influenza Market Value by Application (2024 VS 2031)

1.3.2 Influenza A

1.3.3 Influenza B

1.4 Global Antiviral Medications for Seasonal Influenza Market Size Estimates and Forecasts

1.4.1 Global Antiviral Medications for Seasonal Influenza Revenue 2020-2031

1.4.2 Global Antiviral Medications for Seasonal Influenza Sales 2020-2031

1.4.3 Global Antiviral Medications for Seasonal Influenza Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antiviral Medications for Seasonal Influenza Market Competition by Manufacturers

2.1 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antiviral Medications for Seasonal Influenza Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antiviral Medications for Seasonal Influenza, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antiviral Medications for Seasonal Influenza, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antiviral Medications for Seasonal Influenza, Product Type & Application

2.7 Global Key Manufacturers of Antiviral Medications for Seasonal Influenza, Date of Enter into This Industry

2.8 Global Antiviral Medications for Seasonal Influenza Market Competitive Situation and Trends

2.8.1 Global Antiviral Medications for Seasonal Influenza Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antiviral Medications for Seasonal Influenza Players Market Share by Revenue

2.8.3 Global Antiviral Medications for Seasonal Influenza Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antiviral Medications for Seasonal Influenza Market Scenario by Region

3.1 Global Antiviral Medications for Seasonal Influenza Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antiviral Medications for Seasonal Influenza Sales by Region: 2020-2031

3.2.1 Global Antiviral Medications for Seasonal Influenza Sales by Region: 2020-2025

3.2.2 Global Antiviral Medications for Seasonal Influenza Sales by Region: 2026-2031

3.3 Global Antiviral Medications for Seasonal Influenza Revenue by Region: 2020-2031

3.3.1 Global Antiviral Medications for Seasonal Influenza Revenue by Region: 2020-2025

3.3.2 Global Antiviral Medications for Seasonal Influenza Revenue by Region: 2026-2031

3.4 North America Antiviral Medications for Seasonal Influenza Market Facts & Figures by Country

3.4.1 North America Antiviral Medications for Seasonal Influenza Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2031)

3.4.3 North America Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antiviral Medications for Seasonal Influenza Market Facts & Figures by Country

3.5.1 Europe Antiviral Medications for Seasonal Influenza Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antiviral Medications for Seasonal Influenza Sales by Country (2020-2031)

3.5.3 Europe Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antiviral Medications for Seasonal Influenza Market Facts & Figures by Region

3.6.1 Asia Pacific Antiviral Medications for Seasonal Influenza Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antiviral Medications for Seasonal Influenza Sales by Region (2020-2031)

3.6.3 Asia Pacific Antiviral Medications for Seasonal Influenza Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antiviral Medications for Seasonal Influenza Market Facts & Figures by Country

3.7.1 Latin America Antiviral Medications for Seasonal Influenza Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2031)

3.7.3 Latin America Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Antiviral Medications for Seasonal Influenza Market Facts & Figures by Country

3.8.1 Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antiviral Medications for Seasonal Influenza Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antiviral Medications for Seasonal Influenza Sales by Type (2020-2031)

4.1.1 Global Antiviral Medications for Seasonal Influenza Sales by Type (2020-2025)

4.1.2 Global Antiviral Medications for Seasonal Influenza Sales by Type (2026-2031)

4.1.3 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2031)

4.2 Global Antiviral Medications for Seasonal Influenza Revenue by Type (2020-2031)

4.2.1 Global Antiviral Medications for Seasonal Influenza Revenue by Type (2020-2025)

4.2.2 Global Antiviral Medications for Seasonal Influenza Revenue by Type (2026-2031)

4.2.3 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Type (2020-2031)

4.3 Global Antiviral Medications for Seasonal Influenza Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antiviral Medications for Seasonal Influenza Sales by Application (2020-2031)

5.1.1 Global Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025)

5.1.2 Global Antiviral Medications for Seasonal Influenza Sales by Application (2026-2031)

5.1.3 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2031)

5.2 Global Antiviral Medications for Seasonal Influenza Revenue by Application (2020-2031)

5.2.1 Global Antiviral Medications for Seasonal Influenza Revenue by Application (2020-2025)

5.2.2 Global Antiviral Medications for Seasonal Influenza Revenue by Application (2026-2031)

5.2.3 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Application (2020-2031)

5.3 Global Antiviral Medications for Seasonal Influenza Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Company Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Antiviral Medications for Seasonal Influenza Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Roche Antiviral Medications for Seasonal Influenza Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 HEC Pharma

6.2.1 HEC Pharma Company Information

6.2.2 HEC Pharma Description and Business Overview

6.2.3 HEC Pharma Antiviral Medications for Seasonal Influenza Sales, Revenue and Gross Margin (2020-2025)

6.2.4 HEC Pharma Antiviral Medications for Seasonal Influenza Product Portfolio

6.2.5 HEC Pharma Recent Developments/Updates

6.3 Qilu Pharmaceutical

6.3.1 Qilu Pharmaceutical Company Information

6.3.2 Qilu Pharmaceutical Description and Business Overview

6.3.3 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Portfolio

6.3.5 Qilu Pharmaceutical Recent Developments/Updates

6.4 CSPC

6.4.1 CSPC Company Information

6.4.2 CSPC Description and Business Overview

6.4.3 CSPC Antiviral Medications for Seasonal Influenza Sales, Revenue and Gross Margin (2020-2025)

6.4.4 CSPC Antiviral Medications for Seasonal Influenza Product Portfolio

6.4.5 CSPC Recent Developments/Updates

6.5 Kelun

6.5.1 Kelun Company Information

6.5.2 Kelun Description and Business Overview

6.5.3 Kelun Antiviral Medications for Seasonal Influenza Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Kelun Antiviral Medications for Seasonal Influenza Product Portfolio

6.5.5 Kelun Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antiviral Medications for Seasonal Influenza Industry Chain Analysis

7.2 Antiviral Medications for Seasonal Influenza Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antiviral Medications for Seasonal Influenza Production Mode & Process Analysis

7.4 Antiviral Medications for Seasonal Influenza Sales and Marketing

7.4.1 Antiviral Medications for Seasonal Influenza Sales Channels

7.4.2 Antiviral Medications for Seasonal Influenza Distributors

7.5 Antiviral Medications for Seasonal Influenza Customer Analysis

8 Antiviral Medications for Seasonal Influenza Market Dynamics

8.1 Antiviral Medications for Seasonal Influenza Industry Trends

8.2 Antiviral Medications for Seasonal Influenza Market Drivers

8.3 Antiviral Medications for Seasonal Influenza Market Challenges

8.4 Antiviral Medications for Seasonal Influenza Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Antiviral Medications for Seasonal Influenza Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antiviral Medications for Seasonal Influenza Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antiviral Medications for Seasonal Influenza Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antiviral Medications for Seasonal Influenza Sales (kg) of Key Manufacturers (2020-2025)

Table 5. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antiviral Medications for Seasonal Influenza Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antiviral Medications for Seasonal Influenza Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antiviral Medications for Seasonal Influenza Average Price (US$/g) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antiviral Medications for Seasonal Influenza, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antiviral Medications for Seasonal Influenza, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antiviral Medications for Seasonal Influenza, Product Type & Application

Table 12. Global Key Manufacturers of Antiviral Medications for Seasonal Influenza, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antiviral Medications for Seasonal Influenza by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Medications for Seasonal Influenza as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antiviral Medications for Seasonal Influenza Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (kg)

Table 18. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2020-2025)

Table 19. Global Antiviral Medications for Seasonal Influenza Sales by Region (2026-2031) & (kg)

Table 20. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2026-2031)

Table 21. Global Antiviral Medications for Seasonal Influenza Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2020-2025)

Table 23. Global Antiviral Medications for Seasonal Influenza Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2026-2031)

Table 25. North America Antiviral Medications for Seasonal Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (kg)

Table 27. North America Antiviral Medications for Seasonal Influenza Sales by Country (2026-2031) & (kg)

Table 28. North America Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antiviral Medications for Seasonal Influenza Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antiviral Medications for Seasonal Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (kg)

Table 32. Europe Antiviral Medications for Seasonal Influenza Sales by Country (2026-2031) & (kg)

Table 33. Europe Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antiviral Medications for Seasonal Influenza Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antiviral Medications for Seasonal Influenza Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (kg)

Table 37. Asia Pacific Antiviral Medications for Seasonal Influenza Sales by Region (2026-2031) & (kg)

Table 38. Asia Pacific Antiviral Medications for Seasonal Influenza Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antiviral Medications for Seasonal Influenza Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antiviral Medications for Seasonal Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (kg)

Table 42. Latin America Antiviral Medications for Seasonal Influenza Sales by Country (2026-2031) & (kg)

Table 43. Latin America Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antiviral Medications for Seasonal Influenza Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antiviral Medications for Seasonal Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (kg)

Table 47. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales by Country (2026-2031) & (kg)

Table 48. Middle East and Africa Antiviral Medications for Seasonal Influenza Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antiviral Medications for Seasonal Influenza Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antiviral Medications for Seasonal Influenza Sales (kg) by Type (2020-2025)

Table 51. Global Antiviral Medications for Seasonal Influenza Sales (kg) by Type (2026-2031)

Table 52. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)

Table 53. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2026-2031)

Table 54. Global Antiviral Medications for Seasonal Influenza Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antiviral Medications for Seasonal Influenza Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Type (2020-2025)

Table 57. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Type (2026-2031)

Table 58. Global Antiviral Medications for Seasonal Influenza Price (US$/g) by Type (2020-2025)

Table 59. Global Antiviral Medications for Seasonal Influenza Price (US$/g) by Type (2026-2031)

Table 60. Global Antiviral Medications for Seasonal Influenza Sales (kg) by Application (2020-2025)

Table 61. Global Antiviral Medications for Seasonal Influenza Sales (kg) by Application (2026-2031)

Table 62. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)

Table 63. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2026-2031)

Table 64. Global Antiviral Medications for Seasonal Influenza Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antiviral Medications for Seasonal Influenza Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Application (2020-2025)

Table 67. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Application (2026-2031)

Table 68. Global Antiviral Medications for Seasonal Influenza Price (US$/g) by Application (2020-2025)

Table 69. Global Antiviral Medications for Seasonal Influenza Price (US$/g) by Application (2026-2031)

Table 70. Roche Company Information

Table 71. Roche Description and Business Overview

Table 72. Roche Antiviral Medications for Seasonal Influenza Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 73. Roche Antiviral Medications for Seasonal Influenza Product

Table 74. Roche Recent Developments/Updates

Table 75. HEC Pharma Company Information

Table 76. HEC Pharma Description and Business Overview

Table 77. HEC Pharma Antiviral Medications for Seasonal Influenza Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 78. HEC Pharma Antiviral Medications for Seasonal Influenza Product

Table 79. HEC Pharma Recent Developments/Updates

Table 80. Qilu Pharmaceutical Company Information

Table 81. Qilu Pharmaceutical Description and Business Overview

Table 82. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 83. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product

Table 84. Qilu Pharmaceutical Recent Developments/Updates

Table 85. CSPC Company Information

Table 86. CSPC Description and Business Overview

Table 87. CSPC Antiviral Medications for Seasonal Influenza Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 88. CSPC Antiviral Medications for Seasonal Influenza Product

Table 89. CSPC Recent Developments/Updates

Table 90. Kelun Company Information

Table 91. Kelun Description and Business Overview

Table 92. Kelun Antiviral Medications for Seasonal Influenza Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. Kelun Antiviral Medications for Seasonal Influenza Product

Table 94. Kelun Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Antiviral Medications for Seasonal Influenza Distributors List

Table 98. Antiviral Medications for Seasonal Influenza Customers List

Table 99. Antiviral Medications for Seasonal Influenza Market Trends

Table 100. Antiviral Medications for Seasonal Influenza Market Drivers

Table 101. Antiviral Medications for Seasonal Influenza Market Challenges

Table 102. Antiviral Medications for Seasonal Influenza Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antiviral Medications for Seasonal Influenza

Figure 2. Global Antiviral Medications for Seasonal Influenza Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antiviral Medications for Seasonal Influenza Market Share by Type: 2024 & 2031

Figure 4. Baloxavir marboxil Product Picture

Figure 5. Oseltamivir Product Picture

Figure 6. Zanamivir Product Picture

Figure 7. Peramivir Product Picture

Figure 8. Global Antiviral Medications for Seasonal Influenza Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Antiviral Medications for Seasonal Influenza Market Share by Application: 2024 & 2031

Figure 10. Influenza A

Figure 11. Influenza B

Figure 12. Global Antiviral Medications for Seasonal Influenza Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Antiviral Medications for Seasonal Influenza Market Size (2020-2031) & (US$ Million)

Figure 14. Global Antiviral Medications for Seasonal Influenza Sales (2020-2031) & (kg)

Figure 15. Global Antiviral Medications for Seasonal Influenza Average Price (US$/g) & (2020-2031)

Figure 16. Antiviral Medications for Seasonal Influenza Report Years Considered

Figure 17. Antiviral Medications for Seasonal Influenza Sales Share by Manufacturers in 2024

Figure 18. Global Antiviral Medications for Seasonal Influenza Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Antiviral Medications for Seasonal Influenza Players: Market Share by Revenue in Antiviral Medications for Seasonal Influenza in 2024

Figure 20. Antiviral Medications for Seasonal Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Antiviral Medications for Seasonal Influenza Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Antiviral Medications for Seasonal Influenza Sales Market Share by Country (2020-2031)

Figure 23. North America Antiviral Medications for Seasonal Influenza Revenue Market Share by Country (2020-2031)

Figure 24. United States Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Antiviral Medications for Seasonal Influenza Sales Market Share by Country (2020-2031)

Figure 27. Europe Antiviral Medications for Seasonal Influenza Revenue Market Share by Country (2020-2031)

Figure 28. Germany Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2020-2031)

Figure 35. China Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Antiviral Medications for Seasonal Influenza Sales Market Share by Country (2020-2031)

Figure 43. Latin America Antiviral Medications for Seasonal Influenza Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Antiviral Medications for Seasonal Influenza Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Antiviral Medications for Seasonal Influenza Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Antiviral Medications for Seasonal Influenza by Type (2020-2031)

Figure 54. Global Revenue Market Share of Antiviral Medications for Seasonal Influenza by Type (2020-2031)

Figure 55. Global Antiviral Medications for Seasonal Influenza Price (US$/g) by Type (2020-2031)

Figure 56. Global Sales Market Share of Antiviral Medications for Seasonal Influenza by Application (2020-2031)

Figure 57. Global Revenue Market Share of Antiviral Medications for Seasonal Influenza by Application (2020-2031)

Figure 58. Global Antiviral Medications for Seasonal Influenza Price (US$/g) by Application (2020-2031)

Figure 59. Antiviral Medications for Seasonal Influenza Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions